NGeneBio plans third-party allotment of 6,000,000 new shares

NGeneBio · KOSDAQ · 354200 · Nov 10, 2026 · Rights offerings

NGeneBio filed a rights offering for 6,000,000 new shares through third-party allotment, equal to 37.3% of existing shares. The issue amount is ₩6.0bn, with funds intended as operating funds. The amount equals 28.2% of FY2025 revenue by our calculation.

Key facts

New shares6,000,000 shares
New shares as % of existing shares (calculated)37.3%
Issue amount₩6.0bn
Main purpose of fundsOperating funds
Allocation methodThird-party allotment

Comparison

Amount as % of FY2025 revenue (calculated)28.2%
Revenue 2025₩21.2bn
Revenue 2024₩5.7bn
Revenue 2023₩4.4bn

Context

In the 12 months before this filing, the company's rights offering new shares totaled 7,150,000 shares, and potential new shares including this filing equal 81.7% of shares by our calculation.

Key metrics

Potential dilution

CB/BW/EB issued, last 12 months₩0 As of Nov 19, 2026
Rights offering new shares, last 12 months15,150,000 shares As of Nov 10, 2026 Source 1 ↗, Source 2, Source 3
Potential new shares, last 12 months15,150,000 shares As of Nov 10, 2026 Source 1 ↗, Source 2, Source 3
Potential new shares, % of shares94.2% As of Nov 10, 2026 Source 1 ↗, Source 2, Source 3, Source 4 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Related filings

Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)